Jan 16, 2025 · “DEA’s goal is to provide telehealth access for needed medications while ensuring patient safety and preventing the diversion of medications into the illicit drug market,” said DEA Administrator Anne Milgram. “We understand the difficulties some patients have accessing medical providers in-person, and we want to ease this burden while ...

Nov 15, 2024 · However, with the end of 2024 quickly approaching, DEA, jointly with HHS, has extended current telemedicine flexibilities through December 31, 2025. The full text of the extension, entitled “Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications,” was submitted to the Federal Register ...

Oct 6, 2023 · Accordingly, DEA, jointly with the Department of Health and Human Services (HHS), has extended current telemedicine flexibilities through December 31, 2024. The full text of the extension, entitled “Second Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications,” was submitted to the Federal ...

Nov 15, 2024 · The Drug Enforcement Administration (DEA) in concert with the Department of Health and Human Services (HHS) issued a third extension of telemedicine flexibilities for the prescribing of controlled medications, through December 31, 2025.

On September 12 and 13, 2023, DEA hosted public listening sessions and received comments from 58 healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine.

DEA has granted this exception through the duration of the COVID-19 public health emergency as declared by the Secretary of Health and Human Services. The CSA also authorizes the practice of telemedicine by a practitioner registered in any state

Jan 23, 2025 · The U.S. Drug Enforcement Agency (DEA) announced on Jan. 16, 2025, three new rules intended to implement patient protections and permanently extend certain COVID-era telemedicine prescription flexibilities. These new rules apply only in circumstances where the patient has not had an in-person visit with a medical provider.

Jan 16, 2025 · DEA's new rules enable special registrations for telehealth prescriptions of Schedule II-V medications, bypassing in-person evaluations. Expanded buprenorphine access allows a 6-month supply via telehealth, with subsequent prescriptions requiring in-person visits.

Jan 22, 2025 · The State Telemedicine Registration is a DEA (not-state) registration requirement. The State Telemedicine Registration for a given state would allow the special registrant to prescribe only via telemedicine encounters as to that state, and only for the scheduled controlled substances authorized by the registrant’s respective Special Registration.

Jan 21, 2025 · In the final days of the Biden administration, the Drug Enforcement Administration (DEA) released a proposed rule that would allow practitioners with a Special Registration to prescribe Schedule III-V, and in limited circumstances Schedule II, controlled substances via telemedicine.. Practitioners with a Special Registration would still need to obtain a DEA registration in each state where ...